These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9669932)

  • 41. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120.
    Rizzuto C; Sodroski J
    AIDS Res Hum Retroviruses; 2000 May; 16(8):741-9. PubMed ID: 10826481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.
    Painter SL; Biek R; Holley DC; Poss M
    J Virol; 2003 Aug; 77(15):8448-61. PubMed ID: 12857914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CCR5 interactions with the variable 3 loop of gp120.
    Napier KB; Wang ZX; Peiper SC; Trent JO
    J Mol Model; 2007 Jan; 13(1):29-41. PubMed ID: 16721558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
    Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
    FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
    Liu S; Fan S; Sun Z
    J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural features of HIV envelope defined by antibody escape mutant analysis.
    D'Costa S; Slobod KS; Webster RG; White SW; Hurwitz JL
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1205-9. PubMed ID: 11522189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.
    Labrijn AF; Poignard P; Raja A; Zwick MB; Delgado K; Franti M; Binley J; Vivona V; Grundner C; Huang CC; Venturi M; Petropoulos CJ; Wrin T; Dimitrov DS; Robinson J; Kwong PD; Wyatt RT; Sodroski J; Burton DR
    J Virol; 2003 Oct; 77(19):10557-65. PubMed ID: 12970440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solution structure of a putative HIV1 immunogenic peptide: computer simulation of the principal CD4 binding domain of gp120.
    Mihailescu D; Smith JC; Reed J
    J Med Chem; 2002 Feb; 45(5):1019-25. PubMed ID: 11855981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee.
    Nicely NI; Wiehe K; Kepler TB; Jaeger FH; Dennison SM; Rerks-Ngarm S; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Robb ML; O'Connell RJ; Michael NL; Kim JH; Liao HX; Munir Alam S; Hwang KK; Bonsignori M; Haynes BF
    EBioMedicine; 2015 Jul; 2(7):713-22. PubMed ID: 26288844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.
    Antell GC; Dampier W; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; Schwartz G; Hershberg U; Krebs FC; Wigdahl B
    Retrovirology; 2016 May; 13(1):32. PubMed ID: 27143130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AIDS/HIV. A boost for HIV vaccine design.
    Burton DR; Weiss RA
    Science; 2010 Aug; 329(5993):770-3. PubMed ID: 20705840
    [No Abstract]   [Full Text] [Related]  

  • 57. Backbone and C beta assignments of the anti-gp120 antibody Fv fragment complexed with an antigenic peptide.
    Tugarinov V; Levy R; Dahan-Schokoroy A; Anglister J
    J Biomol NMR; 1999 Feb; 13(2):193-4. PubMed ID: 10070760
    [No Abstract]   [Full Text] [Related]  

  • 58. Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization.
    Phad GE; Vázquez Bernat N; Feng Y; Ingale J; Martinez Murillo PA; O'Dell S; Li Y; Mascola JR; Sundling C; Wyatt RT; Karlsson Hedestam GB
    J Immunol; 2015 Jun; 194(12):5903-14. PubMed ID: 25964491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.
    Sterjovski J; Churchill MJ; Ellett A; Wesselingh SL; Ramsland PA; Gorry PR
    Virology; 2012 Oct; 432(2):394-404. PubMed ID: 22818780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.
    Young KR; Teal BE; Brooks Y; Green TD; Bower JF; Ross TM
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1259-68. PubMed ID: 15588348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.